-
Affiliation
-
Faculty of Pharmacy, Department of Pharmacy 病態生理学講座 (Shiba-Kyoritsu)
-
Position
-
Associate Professor
![]() KEIO RESEARCHERS INFORMATION SYSTEM |
Details of a Researcher
このページはJavascriptを使用しています。すべての機能を使用するためにはJavascript を有効にする必要があります。
Matsushita, Maiko
|
慶応義塾大学医学部内科学教室助手
米国スローンケタリング記念癌研究所研究員
慶応義塾大学医学部先端医科学研究所助手
慶応義塾大学薬学部専任講師
慶應義塾大学薬学部准教授
Keio University, Faculty of Medicine
University, Graduated
Keio University, Graduate School, Division of Medicine
Graduate School, Completed, Doctoral course
Life Science / Immunology
Life Science / General internal medicine (General Internal Medicine (includes Psychosomatic Medicine))
Life Science / Hematology and medical oncology
Oncology
Development of novel immunotherapy against cancer,
フィジカルアセスメントに基づく症例解析と薬物治療
大林恭子,中村智徳, 京都廣川書店, 2021.08
臨床薬学テキストシリーズ 血液・造血器・感染症・悪性腫瘍
乾賢一,望月眞弓,加藤裕久,服部豊, 中山書店, 2021.06, Page: 28-35
Characteristics of a Novel Target Antigen Against Myeloma Cells for Immunotherapy
Maiko Matsushita, Saku Saito, Shinya Yokoe, Daiju Ichikawa and Yutaka Hattori
Vaccines (MDPI) 8 ( 4 ) 579 - 591 2020.10
Research paper (scientific journal), Accepted
A Study on the Description of Anticancer Drug Combination Therapy in Package Insert
Shibata S, Matsushita M, Tsukamoto K, Chiba K, Ozaki K, Suzuki T
BPB Reports (The Pharmaceutical Society of Japan) 3 ( 5 ) 157 - 165 2020.10
Research paper (scientific journal), Joint Work, Accepted
Karigane D., Kasahara H., Shiroshita K., Fujita S., Kobayashi H., Tamaki S., Yamazaki R., Yahagi K., Yatabe Y., Kondoh N., Arai T., Katagiri H., Shimizu N., Sakurai M., Kikuchi T., Kato J., Shimizu T., Hayakawa T., Yaguchi T., Matsushita M., Nakajima H., Kawakami Y., Murata M., Mori T., Sasaki T., Okamoto S., Takubo K.
Leukemia and Lymphoma (Taylor & Francis) 62 ( 3 ) 679 - 687 2020.10
Research paper (scientific journal), Joint Work, Accepted, ISSN 10428194
A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells
Ichikawa D., Nakamura M., Murota W., Osawa S., Matsushita M., Yanagawa H., Hattori Y.
Biochemical and Biophysical Research Communications (ELSEVIER) 521 ( 1 ) 252 - 258 2020.01
Research paper (scientific journal), Accepted, ISSN 0006291X
Okayama M, Kitabatake S, Sato M, Fujimori K, Ichikawa D, Matsushita M, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Hirao M, Kunieda H, Osada M, Okamoto S, Hattori Y
Biochem Biophys Res Commun (Biochemical and Biophysical Research Communications) 505 ( 3 ) 787 - 793 2018.10
Research paper (scientific journal), Joint Work, Accepted, ISSN 0006291X
Identification of strong immunomodulatory drugs using drug-gene interaction database
Matsushita, Maiko
福澤諭吉記念慶應義塾学事振興基金事業報告集 (福澤基金運営委員会) 2020
Development of combined immunotherapy targeting prostate cancer stem cells
Matsushita, Maiko
学事振興資金研究成果実績報告書 (慶應義塾大学) 2017
Development of novel immunotherapy targeting leukemic stem cells.
Matsushita, Maiko
科学研究費補助金研究成果報告書 2016
Analysis of induction mechanisms for tumor antigen-specific regulatory T cells in lymphoma
Matsushita, Maiko
科学研究費補助金研究成果報告書 2009
Novel treatment strategies utilizing immune reactions against chronic myelogenous leukemia stem cells
Matsushita M
Cancers (MDPI) 13 ( 21 ) 5435 2021.11
Article, review, commentary, editorial, etc. (scientific journal), Single Work
Immunogenic cell death in hematological malignancies.
Matsushita M.
臨床血液 (日本血液学会) 62 ( 7 ) 709 - 716 2021.07
Article, review, commentary, editorial, etc. (scientific journal), Single Work
Immunomodulatory effects of drugs for effective cancer immunotherapy.
Matsushita M,Kawaguchi M.
Journal of Oncology ID 8653489 2018.10
Article, review, commentary, editorial, etc. (scientific journal), Joint Work
Immunotherapy Targeting Leukemia Stem Cells.
Matsushita M
International Journal of Hematological Disorders (Science and Education Publishing) 39 - 42 2015.07
Article, review, commentary, editorial, etc. (scientific journal), Single Work
造血器腫瘍における免疫療法.
松下麻衣子.
産科と婦人科 (診断と治療社) 81(2) 217-222 2014.02
Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media), Single Work
既存の多発性骨髄腫治療薬がオートファジー経路に及ぼす影響
Ryo Kaneko, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori
Poster presentation
多発性骨髄腫における免疫原生細胞死に寄与するシグナル経路の検討
Yuta Shimizu, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori
第46回日本骨髄腫学会学術集会,
Poster presentation
前立腺癌幹細胞を標的とした免疫療法の基礎的検討
松下麻衣子,清水湧太,田中洸太郎,須田ゆきの,横江信哉,小坂威雄,大家基嗣,市川大樹,服部豊
第18回日本免疫治療学会学術集会,
Poster presentation
A novel candidate for immunological target in treatment of multiple myeloma.
Maiko Matsushita, Saku Saito, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
An AACR Special Conference on Tumor Immunology and Immunotherapy,
Poster presentation
骨髄腫細胞においてリプログラミング遺伝子による脱分化が薬剤抵抗性とクローン増殖性を増強する
辻宏樹,不藤 拓海, 佐俣 光一, 山元 智史, 市川 大樹, 松下 麻衣子, 服部 豊
第81回日本血液学会学術集会 (東京) ,
Media coverage, 日本血液学会
Development of novel combined immunotherapy using in silico screening system
MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Principal investigator
Development of novel immunotherapy targeting leukemic stem cells.
MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Principal investigator
フェニルフタルイミド修飾体及びそれを有効成分とする医薬組成物
Date applied: 2016-207402 2016.10
Patent, Joint
化合物もしくはその薬理学的に許容される塩、抗腫瘍剤、又は活性酸素産生剤
Date applied: 2016-031897 2016.02
Date published: 2017-149658 2017.08
Patent, Joint
ペプチド、樹状細胞、細胞傷害性T細胞、白血病ワクチン、及び白血病受動免疫療法剤
Date applied: 2013-194119 2013.09
Date announced: 2015-71543 2015.04
Date issued: 6204130 2017.09
Patent, Joint
がん免疫療法
Date applied: 2012-132288 2012.06
Date announced: 2013-256454(P2013-256454A) 2013.12
Date issued: 5984113 2016.08
Patent, Joint
日本骨髄腫学会奨励賞
松下麻衣子, 2015.05, 日本骨髄腫学会, 新規ホメオボックス蛋白由来抗原を用いた多発性骨髄腫に対する複合的免疫治療法の開発
Type of Award: Award from Japanese society, conference, symposium, etc.
日本白血病研究基金一般研究賞
松下麻衣子, 2013.11, 日本白血病研究基金, 新規癌抗原を標的とした多発性骨髄腫に対する免疫治療法の開発
Type of Award: Award from publisher, newspaper, foundation, etc.
BACHELOR'S THESIS
2022
ADVANCED PHARMACOTHERAPY
2022
ADVANCED MOLECULAR BIOLOGY OF DISEASE
2022
BIOTECH-DISCOVERY-BASED MEDICINE AND GENOME INFORMATICS
2022
STUDY OF MAJOR FIELD: (CLINICAL PHYSIOLOGY AND THERAPEUTICS)
2022